Your browser doesn't support javascript.
loading
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos, Jacqueline C; O'Brien, Susan; Brown, Jennifer R; Kay, Neil E; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine; Mulligan, Stephen; Jaeger, Ulrich; Devereux, Stephen; Pocock, Christopher; Robak, Tadeusz; Schuster, Stephen J; Schuh, Anna; Gill, Devinder; Bloor, Adrian; Dearden, Claire; Moreno, Carol; Cull, Gavin; Hamblin, Mike; Jones, Jeffrey A; Eckert, Karl; Solman, Isabelle G; Suzuki, Samuel; Hsu, Emily; James, Danelle F; Byrd, John C; Hillmen, Peter.
Afiliação
  • Barrientos JC; Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY. Electronic address: jbarrientos@northwell.edu.
  • O'Brien S; University of California Irvine, Chao Family Comprehensive Cancer Center, Irvine, CA.
  • Brown JR; Dana-Farber Cancer Institute, Boston, MA.
  • Kay NE; Mayo Clinic, Rochester, MN.
  • Reddy NM; Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Coutre S; Stanford University School of Medicine, Stanford, CA.
  • Tam C; Peter MacCallum Cancer Centre and St Vincent's Hospital, Melbourne, Australia.
  • Mulligan S; Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  • Jaeger U; Medical University of Vienna, Vienna, Austria.
  • Devereux S; King's College Hospital, NHS Foundation Trust, London, United Kingdom.
  • Pocock C; East Kent Hospitals University, NHS Foundation Trust, Canterbury, United Kingdom.
  • Robak T; Medical University of Lodz, Lodz, Poland.
  • Schuster SJ; Perelman Center for Advanced Medicine, Philadelphia, PA.
  • Schuh A; Oxford National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Gill D; Princess Alexandra Hospital, Brisbane, Australia.
  • Bloor A; The Christie Clinic, Manchester, United Kingdom.
  • Dearden C; The Royal Marsden Hospital, NHS Foundation Trust, London, UK.
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Cull G; Sir Charles Gardiner Hospital, Nedlands, WA, Australia.
  • Hamblin M; Colchester Hospital, NHS Foundation Trust, Essex, United Kingdom.
  • Jones JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Eckert K; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Solman IG; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Suzuki S; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Hsu E; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • James DF; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Byrd JC; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Hillmen P; The Leeds Teaching Hospitals, St. James University Hospital, Leeds, United Kingdom.
Clin Lymphoma Myeloma Leuk ; 18(12): 803-813.e7, 2018 12.
Article em En | MEDLINE | ID: mdl-30249389

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article